Key result
The MOGE(S) classification provides a standardized nomenclature for cardiomyopathy, facilitating better phenotype-genotype correlation globally.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
May support standardized cardiomyopathy nomenclature in research; leaves open prospective validation of clinical utility.
Global Heart is the official and primary publication of the World Heart Federation, offering a platform for the dissemination of knowledge on research, developments, trends, solutions and public health programmes in the area of cardiovascular disease. Global Heart welcomes research results, points of view and educational material on the prevention, treatment and control of cardiovascular disease with a special focus on low and middle-income countries which are facing the brunt of epidemiological transition.Global Heart strongly encourages authors to adhere to CONSORT, STROBE, STARD, and PRISMA guidelines for reporting of clinical trials, observational studies, diagnostic test accuracy papers, and systematic reviews or meta-analyses. Authors are required for submission to download and complete the appropriate Equator Network checklist: http://www.equator-network.org/.
No takes yet. Share an insight, caveat, or question.
Arbustini et al. (2013) studied this question. The MOGE(S) classification provides a standardized nomenclature for cardiomyopathy, facilitating better phenotype-genotype correlation globally.
Synapse has enriched 10 related papers. Consider them for comparative context: